Shehnaaz Suliman, M.D.
Board Member
Ultragenyx Pharmaceutical Inc. (RARE)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Shehnaaz Suliman, M.D.
Shehnaaz Suliman, M.D. is recorded as Board Member at Ultragenyx Pharmaceutical Inc. (RARE). Ultragenyx Pharmaceutical Inc. reported in an 8-K filed May 18, 2026 that Shehnaaz Suliman, M.D. was appointed Class I Director, effective May 14, 2026. Ultragenyx Pharmaceutical Inc. reported in an 8-K filed June 13, 2023 that Shehnaaz Suliman, M.D. was appointed Class I Director, effective June 7, 2023.
“At the Annual Meeting, the Company's stockholders elected the Class I director nominees below to the Company's Board of Directors to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected.”
“At the Annual Meeting, the Company's stockholders elected the Class I director nominees below to the Company's Board of Directors to hold office until the 2026 Annual Meeting of Stockholders or until their successors are elected.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-06-07–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Ultragenyx Pharmaceutical Inc.
Other people whose current roles at this company are on record from its filings.
- Emil D. Kakkis CEO, Board Member
- Emil Kakkis CEO, Board Member
- Howard Horn CFO
- Eric Crombez, M.D. CTO
- Karah Parschauer General Counsel
- Amrit Ray, M.D. Board Member
- Clay B. Siegall Board Member
- Continuing Directors Board Member
- Corazon (Corsee) D. Sanders, Ph.D. Board Member
- Corsee Sanders, Ph.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.